CD274 and non-small cell lung carcinoma: It downregulates PD‐L1 expression by enhancing the ubiquitination of PD‐L1 mediated by the E3 ligase Trim21, thereby improving the effectiveness of NSCLC treatment with anti‐PD‐L1 therapy [44].